BioPharma Credit PLC is a United Kingdom-based, closed-ended investment trust. The principal activity of the Company is to invest in interest-bearing-debt assets with a contractual right to future cash flows derived from royalties or sales of approved life sciences products. The Company’s investment objective is to generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve its investment objectives through direct or indirect exposure to debt assets. Its diversified portfolio is primarily secured by cash flows derived from sales of approved life sciences products. The Company holds a majority of its investments through its financing subsidiary, BPCR Limited Partnership. Its portfolio of investments includes senior secured corporate loans, senior secured royalty loans, unsecured convertible bonds, and equity. The Company’s investment manager is Pharmakon Advisors L.P.